Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Christopher D. Fletcher & Brad S. Kahl. (2014) Central nervous system involvement in diffuse large B-cell lymphoma: an analysis of risks and prevention strategies in the post-rituximab era. Leukemia & Lymphoma 55:10, pages 2228-2240.
Read now
Read now
Koen Van Besien, Christian Gisselbrecht, Michael Pfreundschuh & Emanuele Zucca. (2008) Secondary lymphomas of the central nervous system: risk, prophylaxis and treatment. Leukemia & Lymphoma 49:sup1, pages 52-58.
Read now
Read now
Articles from other publishers (28)
Ng Kwang Sheng, Wan-Hazabbah Wan Hitam & Nurul Ain Masnon. (2022) Infiltration of Bilateral Optic Nerves in Burkitt Lymphoma: A Case Report. Cureus.
Crossref
Crossref
Nicolas Gallastegui, Daniel P. Cassidy, Deborah O. Heros, Francisco Vega & Jonathan H. Schatz. (2019) Central Nervous System Involvement by Small Lymphocytic Lymphoma after a Myxoma-Related Embolic Event. Case Reports in Hematology 2019, pages 1-6.
Crossref
Crossref
Yoo Sung Song, Won Woo Lee, Jong Seok Lee & Sang Eun Kim. (2015) Prediction of Central Nervous System Relapse of Diffuse Large B-Cell Lymphoma Using Pretherapeutic [18F]2-Fluoro-2-Deoxyglucose (FDG) Positron Emission Tomography/Computed Tomography. Medicine 94:44, pages e1978.
Crossref
Crossref
Abhimanyu Ghose, Ria Kundu & Tahir Latif. (2014) Prophylactic CNS directed therapy in systemic diffuse large B cell lymphoma. Critical Reviews in Oncology/Hematology 91:3, pages 292-303.
Crossref
Crossref
Hany R. Guirguis, Matthew C. Cheung, Mervat Mahrous, Eugenia Piliotis, Neil Berinstein, Kevin R. Imrie, Liying Zhang & Rena Buckstein. (2012)
Impact of central nervous system (
CNS
) prophylaxis on the incidence and risk factors for
CNS
relapse in patients with diffuse large
B
‐cell lymphoma treated in the rituximab era: a single centre experience and review of the literature
. British Journal of Haematology 159:1, pages 39-49.
Crossref
Crossref
Anita Kumar, Ann Vanderplas, Ann S. LaCasce, Maria A. Rodriguez, Allison L. Crosby, Eva Lepisto, Myron S. Czuczman, Auayporn Nademanee, Joyce Niland, Leo I. Gordon, Michael Millenson, Andrew D. Zelenetz, Jonathan W. Friedberg & Gregory A. Abel. (2011) Lack of benefit of central nervous system prophylaxis for diffuse large B‐cell lymphoma in the rituximab era. Cancer 118:11, pages 2944-2951.
Crossref
Crossref
Hanny Haaxma-Reiche. 2012. Neuro-Oncology Part II. Neuro-Oncology Part II
711
729
.
Mustafa Khasraw, Ariela Noy, Mark Gilbert & Antonio Omuro. 2012. Lymphoma and Leukemia of the Nervous System. Lymphoma and Leukemia of the Nervous System
267
285
.
Robert Kridel & Pierre-Yves Dietrich. (2011) Prevention of CNS relapse in diffuse large B-cell lymphoma. The Lancet Oncology 12:13, pages 1258-1266.
Crossref
Crossref
Fabio Canova, Dario Marino, Chiara Trentin, Caterina Soldà, Cristina Ghiotto & Savina Maria Luciana Aversa. (2011) Intrathecal chemotherapy in lymphomatous meningitis. Critical Reviews in Oncology/Hematology 79:2, pages 127-134.
Crossref
Crossref
J.H. Yi, J.H. Kim, K.K. Baek, T. Lim, D.J. Lee, Y.C. Ahn, K. Kim, S.J. Kim, Y.H. Ko & W.S. Kim. (2011) Elevated LDH and paranasal sinus involvement are risk factors for central nervous system involvement in patients with peripheral T-cell lymphoma. Annals of Oncology 22:7, pages 1636-1643.
Crossref
Crossref
Kazuyuki Shimada, Takuhei Murase, Kosei Matsue, Masataka Okamoto, Naoaki Ichikawa, Norifumi Tsukamoto, Nozomi Niitsu, Hiroshi Miwa, Hideki Asaoku, Hiroshi Kosugi, Ako Kikuchi, Morio Matsumoto, Yoshio Saburi, Yasufumi Masaki, Kazuhito Yamamoto, Motoko Yamaguchi, Shigeo Nakamura, Tomoki Naoe & Tomohiro Kinoshita. (2010) Central nervous system involvement in intravascular large B‐cell lymphoma: A retrospective analysis of 109 patients. Cancer Science 101:6, pages 1480-1486.
Crossref
Crossref
Ulrich Herrlinger, Michael Glantz, Uwe Schlegel, Christian Gisselbrecht & Franco Cavalli. (2009) Should Intra-cerebrospinal Fluid Prophylaxis Be Part of Initial Therapy for Patients With Non-Hodgkin Lymphoma: What We Know, and How We Can Find Out More. Seminars in Oncology 36, pages S25-S34.
Crossref
Crossref
Ching-Hon Pui & Eckhard Thiel. (2009) Central Nervous System Disease in Hematologic Malignancies: Historical Perspective and Practical Applications. Seminars in Oncology 36, pages S2-S16.
Crossref
Crossref
Volkmar BoehmeNorbert SchmitzSamira Zeynalova, Markus Loeffler & Michael Pfreundschuh. (2009) CNS events in elderly patients with aggressive lymphoma treated with modern chemotherapy (CHOP-14) with or without rituximab: an analysis of patients treated in the RICOVER-60 trial of the German High-Grade Non-Hodgkin Lymphoma Study Group (DSHNHL). Blood 113:17, pages 3896-3902.
Crossref
Crossref
Juan-Manuel Sancho, Mireia Morgades, Natalia Alonso, Guillermo Deben, Alberto Fernández de Sevilla, Lourdes Vázquez, Concepción Nicolás, José-Antonio García Vela, Reyes Arranz, Eugenia Abella, Miguel-Ángel Canales, Pilar Miralles, Eva Sánchez, Mar Hermosilla, Eulogio Conde, Antonio Rueda & Josep-Maria Ribera. (2008) Prospective study on the practice of central nervous system prophylaxis and treatment in non-Hodgkin’s lymphoma in Spain. Medicina Clínica 131:12, pages 441-446.
Crossref
Crossref
Juan-Manuel Sancho, Mireia Morgades, Reyes Arranz, Pascual Fernández-Abellán, Guillermo Deben, Natalia Alonso, Margarita Blanes, María José Rodríguez, Concepción Nicolás, Eva Sánchez, Alberto Fernández de Sevilla, Eulogio Conde & Josep-Maria Ribera. (2008) Practice of central nervous system prophylaxis and treatment in acute leukemias in Spain. Prospective registry study. Medicina Clínica 131:11, pages 401-405.
Crossref
Crossref
Hwee Yong Lim, Eckhard Thiel & Michael J Glantz. (2008) To protect and defend: central nervous system prophylaxis in patients with non-Hodgkinʼs lymphoma. Current Opinion in Oncology 20:5, pages 495-501.
Crossref
Crossref
S-S Chuang, W-T Huang, P-P Hsieh, Y-C Jung, H Ye, M-Q Du, C-L Lu, C-Y Cho, S-C Hsiao, Y-H Hsu & K-J Lin. (2008) Sporadic paediatric and adult Burkitt lymphomas share similar phenotypic and genotypic features. Histopathology 52:4, pages 427-435.
Crossref
Crossref
Alireza Minagar, Deborah Commins, J. Steven Alexander, Romy Hoque, Francesco Chiappelli, Elyse J. Singer, Behrooz Nikbin & Paul Shapshak. (2012) NeuroAIDS. Molecular Diagnosis & Therapy 12:1, pages 25-43.
Crossref
Crossref
Matthew C. Cheung, Kevin R. Imrie, Heather A. Leitch, Laura Y. Park-Wyllie, Rena Buckstein, Tony Antoniou & Mona R. Loutfy. (2007) Physician perceptions and preferences in the treatment of acquired immunodeficiency syndrome (AIDS)-related lymphoma. Annals of Hematology 86:9, pages 631-638.
Crossref
Crossref
Nancy D. Doolittle. 2007. Brain Metastases. Brain Metastases
169
183
.
Quentin A. Hill & Roger G. Owen. (2006) CNS prophylaxis in lymphoma: Who to target and what therapy to use. Blood Reviews 20:6, pages 319-332.
Crossref
Crossref
C. W. Cheung, C. Burton, P. Smith, D. C. Linch, P. J. Hoskin & K. M. Ardeshna. (2005) Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK. British Journal of Haematology 131:2, pages 193-200.
Crossref
Crossref
Andrew McMillan. (2005) Central nervous system-directed preventative therapy in adults with lymphoma. British Journal of Haematology 131:1, pages 13-21.
Crossref
Crossref
Philip Bierman & Pierre Giglio. (2005) Diagnosis and Treatment of Central Nervous System Involvement in Non-Hodgkin's Lymphoma. Hematology/Oncology Clinics of North America 19:4, pages 597-609.
Crossref
Crossref
Jeanine Grier & Tracy Batchelor. (2005) Metastatic neurologic complications of non-Hodgkin’s lymphoma. Current Oncology Reports 7:1, pages 55-60.
Crossref
Crossref
Roelien H. Enting. 2005. Leptomeningeal Metastases. Leptomeningeal Metastases
17
30
.